EP1398312A1 - Beta-substituted-gamma-butyrolactones and a process for preparation thereof - Google Patents

Beta-substituted-gamma-butyrolactones and a process for preparation thereof Download PDF

Info

Publication number
EP1398312A1
EP1398312A1 EP20020020643 EP02020643A EP1398312A1 EP 1398312 A1 EP1398312 A1 EP 1398312A1 EP 20020020643 EP20020020643 EP 20020020643 EP 02020643 A EP02020643 A EP 02020643A EP 1398312 A1 EP1398312 A1 EP 1398312A1
Authority
EP
European Patent Office
Prior art keywords
butyrolactone
substituted
phenyl
carbonyloxy
butyrolactones
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP20020020643
Other languages
German (de)
French (fr)
Inventor
Hong-Sun Uh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to EP20020020643 priority Critical patent/EP1398312A1/en
Publication of EP1398312A1 publication Critical patent/EP1398312A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32Oxygen atoms
    • C07D307/33Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form

Definitions

  • the present invention is related to a process for the preparation of (S)- or (R)- ⁇ -substituted- ⁇ -butyrolactones or a racemic mixture thereof.
  • ⁇ -substituted- ⁇ -succinic anhydrides are converted by zinc borohydride in a compatible solvent selected from tetrahydrofuran, methylene chloride, dichloromethane and ethyl acetate to the corresponding ⁇ -substituted- ⁇ -butyrolactones.
  • the ⁇ -substituted- ⁇ -butyrolactones are obtainable in chrystalline form and are useful in the production of pharmaceuticals, agrochemicals, flavors and fragrances. Also disclosed are novel ⁇ -substituted- ⁇ -butyrolactones.
  • alkali metal borohydride particularly sodium borohydride
  • the ⁇ -butyrolactones obtained by the known process are viscous syrupy products. Much labor is required to purify them to commercially satisfactory quality.
  • the object of this invention is to find improved methods for preparing of (S)- or (R)- ⁇ -hydroxy and other substituted- ⁇ -butyrolactones from l-malic acid.
  • the present invention is based on a method first disclosed by Barton, et al., (Tetrahedron Lett. 1982,651) and Hollingsworth (US 5,808,107).
  • l-malic acid 5 is an ester of the l-malic acid 6 is a deesterified diol of 5 7 is 6 reduced to a triol Ia is ⁇ -butyrolactone
  • alkali metal borohydride particularly sodium borohydride
  • zink borohydride as a reducing agent for the conversion of the anhydride to lactone
  • (S)- ⁇ -acetoxy-succinic anhydride 2 made from l-malic acid 4 , can be reduced by sodium borohydride to (S)- ⁇ -acetoxy-butyrolactone Ic in good yield as shown in Scheme II.
  • the ⁇ -butyrolactone Ia and Ic are both viscous syrupy products and their purification to commercially satisfactory quality is laborious.
  • the present inventors have shown that if the ⁇ -hydroxy group of l-malic acid is blocked by a benzoyl group, the resulting (S)- ⁇ -benzoyloxy succinic anhydride 3 is a crystalline compound and can be reduced by sodium borohydride to give crystalline (S)- ⁇ -benzoyloxy- ⁇ -butyrolactone Ie .
  • This product can be recrystallized to meet the quality requirements for production of pharmaceuticals.
  • zinc borohydride is a better reducing agent for the reduction of (S)- ⁇ -acetoxy succinic anhydride 2 and (S)- ⁇ -benzoyloxy-succinic anhyride 3 to the corresponding ⁇ -butyrolactones Ic and Ie, giving better qualities and yields using the syntesis routes shown in Scheme II.
  • Zinc borohydride is also less expensive than other alkali borohydrides.
  • ⁇ -Substituted- ⁇ -butyrolactones of (R)-series are also prepared by the same chemistry applied to (S)-series.
  • Zinc borohydride reduction of the anhydrides is preferred to sodium borohydride with respect to yields and purities.
  • the present invention relates to an improved process for the preparation of ⁇ -substituted- ⁇ -butyrolactones or racemic mixtures thereof having the general formula (I), wherein R 1 is hydrogen, acetyl, benzyl, benzoyl, 2- or 4-nitrophenylcarbonyl, 2- or 4-bromophenyl carbonyl, 2- or 4-chlorophenylcarbonyl, or 1- or 2-naphtylcarbonyl.
  • R 1 is hydrogen, acetyl, benzyl, benzoyl, 2- or 4-nitrophenylcarbonyl, 2- or 4-bromophenyl carbonyl, 2- or 4-chlorophenylcarbonyl, or 1- or 2-naphtylcarbonyl.
  • the (S)- or (R)- ⁇ -substituted- ⁇ -butyrolactones of the formula (I) above of the present invention are obtainable by converting ⁇ -substituted- ⁇ -succinic anhydrides of the formula (2) in the presence of zinc borohydride in a compatible solvent selected from tetrahydrofuran, methylene chloride, dichloromethane and ethyl acetate.
  • ⁇ -substituted- ⁇ -butyrolactones of the formula (I) of the present invention have chiral center at ⁇ -position. Therefore, the compounds of the present invention exist as (S)-isomer(I-1), (R)-isomer(I-2) and racemic mixture thereof.
  • R 1 is benzoyl, 2-or 4-nitrophenylcarbonyl, 2- or 4-bromophenyl carbonyl, 2- or 4-chlorophenylcarbonyl, or 1- or 2-naphthylcarbonyl.
  • the compounds of the present invention can be illustrated as (S)- ⁇ -hydroxy- ⁇ -butyrolactone (Ia), (R)- ⁇ -hydroxy- ⁇ -butyrolactone (Ib), (S)- ⁇ -acetoxy- ⁇ -butyrolactone (Ic), (R)- ⁇ -acetoxy- ⁇ -butyrolactone (Id), (S)- ⁇ -benzyloxy- ⁇ -butyrolactone, (R)- ⁇ -benzyloxy- ⁇ -butyrolactone, (S)- ⁇ -benzoyloxy- ⁇ -butyrolactone (Ie), (R)- ⁇ -benzoyloxy- ⁇ -butyrolactone (If), (S)- ⁇ -[2-nitro(or 4-nitro)phenyl]carbonyloxy- ⁇ -butyrolactone, (R)- ⁇ -[2-nitro(or 4-nitro) phenyl]carbonyloxy- ⁇ -butyrolactone, (S)- ⁇ -[2-chloro-(or 4-chloro
  • compounds (Ia), (Ib), (Ic) and (Id) are known compounds and compounds (Ie) and (If) etc., are novel compounds.
  • Novel compounds of (Ie), (If) and derivatives thereof including (S)-[2-nitro(or 4-nitro)phenyl]carbonyloxy- ⁇ -butyrolactone, (R)-[2-nitro(or 4-nitro)phenyl]carbonyloxy- ⁇ -butyrolactone, (S)- ⁇ -[2-chloro-( or 4-chloro) phenyl]carbonyloxy- ⁇ -butyrolactone, (R)- ⁇ -[2-chloro-(or 4-chloro)phenyl]carbonyloxy- ⁇ -butyrolactone, (S)- ⁇ -[2-bromo-( or 4-bromo)phenyl]carbonyloxy- ⁇ -butyrolactone, (R)- ⁇ -[2-bromo-(or 4-bromo)phenyl]carbonyloxy- ⁇ -butyrolactone, (S)- ⁇ -[1-naphthyl-(or 2-naphthyl)]carbonyloxy- ⁇ -
  • Benzoyl chloride (15.7 g, 111.9 mmole) was added to 1-malic (5.0g, 37.3 mmole) in 10 ml anhydrous THF with stirring at room temperature and heated to 80-85°C, for 3 hours.
  • THF was distilled off under a rotary evaporator and diethyl ether (20ml) was added and stirred.
  • a white solid was filtered, washed with 5ml of diethyl ether and dried to obtain 6.5 g (79.1% yield); m.p. 159-160°C.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Furan Compounds (AREA)

Abstract

Preparation of (S) and/or (R)-beta -substituted-gamma -butyrolactones, or racemic mixture, involves converting beta -substituted-gamma -succinic anhydride with zinc borohydride in tetrahydrofuran, methylene chloride, dichloromethane or ethyl acetate. Preparation of (S) and/or (R)-beta -substituted-gamma -butyrolactones of formula (I) or racemic mixture involves converting beta -substituted-gamma -succinic anhydride of formula (II) with zinc borohydride in tetrahydrofuran, methylene chloride, dichloromethane or ethyl acetate. [Image] R1H, acetyl, benzyl, benzoyl, 2-nitrophenylcarbonyl, 4-nitrophenylcarbonyl, 2-bromophenylcarbonyl, 4-bromophenylcarbonyl, 2-chlorophenylcarbonyl, 4-chlorophenylcarbonyl, or 1-naphthylcarbonyl or 2-naphthylcarbonyl. An independent claim is also included for new (S) and (R) forms of (I) (where R1 is benzoyl, 2-nitrophenylcarbonyl, 4-nitrophenylcarbonyl, 2-bromophenylcarbonyl, 4-bromophenylcarbonyl, 2-chlorophenylcarbonyl, 4-chlorophenylcarbonyl, or 1-naphthylcarbonyl or 2-naphthylcarbonyl).

Description

  • The present invention is related to a process for the preparation of (S)- or (R)-β-substituted-γ-butyrolactones or a racemic mixture thereof. β-substituted-γ-succinic anhydrides are converted by zinc borohydride in a compatible solvent selected from tetrahydrofuran, methylene chloride, dichloromethane and ethyl acetate to the corresponding β-substituted-γ-butyrolactones. The β-substituted-γ-butyrolactones are obtainable in chrystalline form and are useful in the production of pharmaceuticals, agrochemicals, flavors and fragrances. Also disclosed are novel β-substituted-γ-butyrolactones.
  • Methods for preparing β-substituted-γ-butyrolactones are described in the following patents US 3,024,250 (Klein et al.), US 3,868,370 (Smith), US 3,997,569 (Powell), US 4,105,674 (De Thomas et al.), US 4,155,919 (Ramioulle et al.), US 4,772,729 (Rao), US 4,940,805 (Fisher et al.), US 5,292,939 (Hollingsworth), US 5,319,110 (Hollingsworth), US 5,374,773 (Hollingsworth), US 5,502,217 (Fuchikami et al.) and in the following articles Bailey et al., J. Org.Chem. 35 (10) 3574(1970), McAlees et al., J.C.S. Perkin I.2037 (1977), McGarvey et al., J. Am. Chem. Soc., 108, 4943-4952 (1986), Corey et al., J. Am. Chem. Soc., 100, 1942-1943 (1978).
  • The first synthesis of (S)-(-)-β-benzyloxy-γ-butyrolactone starting from ℓ-malic acid was published by Barton et al. in Tetrahedron Lett. 1982, 651. The use of ℓ-malic acid as a precursor for the preparation of (S)-β-hydroxy-γ-butyrolactone was published by Hollingsworth in the patent US 5,808,107. However, the lithium borohydride made in situ from sodium borohydride, and lithium chloride is still expensive and it is difficult to measure the exact quantity necessary for the reduction. Furthermore, an excess of lithium borohydride may overreduce the ester to a triol.
  • Accordingly, the use of alkali metal borohydride, particularly sodium borohydride, as a reducing agent for the conversion of the anhydride to lactone is in general known in the prior art, but the γ-butyrolactones obtained by the known process are viscous syrupy products. Much labor is required to purify them to commercially satisfactory quality.
  • Therefore, there is a need for a further improved process for the preparation of (S)- or (R)-β-hydroxy-γ-butyrolactone from l-malic acid. In particular, the object of this invention is to find improved methods for preparing of (S)- or (R)-β-hydroxy and other substituted-γ-butyrolactones from l-malic acid.
  • The characteristic features of the present invention are as set out in the claims.
  • As said above the present invention is based on a method first disclosed by Barton, et al., (Tetrahedron Lett. 1982,651) and Hollingsworth (US 5,808,107).
  • A route of the syntesis is shown in Scheme I.
    Figure 00020001
       Conditions : (a) CH3OH, H+ ; (b) LiBH4 ; (c) H+
  • In said sheme 4 is ℓ-malic acid
       5 is an ester of the ℓ-malic acid
       6 is a deesterified diol of 5
       7 is 6 reduced to a triol
       Ia is γ-butyrolactone
  • As said above the use of alkali metal borohydride, particularly sodium borohydride, as a reducing agent for the conversion of the anhydride to lactone is known in the prior art, but is replaced by zink borohydride in the present invention.
  • Alternatively, (S)-β-acetoxy-succinic anhydride 2, made from ℓ-malic acid 4, can be reduced by sodium borohydride to (S)-β-acetoxy-butyrolactone Ic in good yield as shown in Scheme II.
    Figure 00030001
    Figure 00030002
  • In Scheme II 4 is ℓ-malic acid
       2 is (S)-β-acetoxy-succinic anhydride
       3 is (S)-β-benzoyloxy succinic anhydride
       Ia is γ-butyrolactone
       Ic is (S)-β-acetoxy-γ-butyrolactone
       Ie is (S)-β-benzoyloxy-γ-butyrolactone
  • The γ-butyrolactone Ia and Ic are both viscous syrupy products and their purification to commercially satisfactory quality is laborious. The present inventors have shown that if the β-hydroxy group of ℓ-malic acid is blocked by a benzoyl group, the resulting (S)-β-benzoyloxy succinic anhydride 3 is a crystalline compound and can be reduced by sodium borohydride to give crystalline (S)-β-benzoyloxy-γ-butyrolactone Ie. This product can be recrystallized to meet the quality requirements for production of pharmaceuticals.
  • The present inventors found that zinc borohydride is a better reducing agent for the reduction of (S)-β-acetoxy succinic anhydride 2 and (S)-β-benzoyloxy-succinic anhyride 3 to the corresponding γ-butyrolactones Ic and Ie, giving better qualities and yields using the syntesis routes shown in Scheme II. Zinc borohydride is also less expensive than other alkali borohydrides.
  • β-Substituted-γ-butyrolactones of (R)-series are also prepared by the same chemistry applied to (S)-series. Zinc borohydride reduction of the anhydrides is preferred to sodium borohydride with respect to yields and purities.
  • Crude (S)- or (R)-β-hydroxy-γ-butyrolactones are water-soluble and viscous compounds. These compounds are as said above very difficult to purify using conventional methods, including for example simple or high-vacuum distillations. The present inventors demonstrated that when (S)- or (R)-β-hydroxy-γ-butyrolactones were benzoylated, the resulting (S)- or (R)-β-hydroxy-γ-butyrolactones Ie and If became crystalline compounds which were easily purified by recrystallizations in a compatible solvent (Scheme III).
    Figure 00040001
  • Accordingly, the present invention relates to an improved process for the preparation of β-substituted-γ-butyrolactones or racemic mixtures thereof having the general formula (I),
    Figure 00040002
    wherein R1 is hydrogen, acetyl, benzyl, benzoyl, 2- or 4-nitrophenylcarbonyl, 2- or 4-bromophenyl carbonyl, 2- or 4-chlorophenylcarbonyl, or 1- or 2-naphtylcarbonyl. The (S)- or (R)-β-substituted-λ-butyrolactones of the formula (I) above of the present invention are obtainable by converting β-substituted-γ-succinic anhydrides of the formula (2) in the presence of zinc borohydride in a compatible solvent selected from tetrahydrofuran, methylene chloride, dichloromethane and ethyl acetate.
  • β-substituted-γ-butyrolactones of the formula (I) of the present invention have chiral center at β-position. Therefore, the compounds of the present invention exist as (S)-isomer(I-1), (R)-isomer(I-2) and racemic mixture thereof.
  • The compounds of the present invention are shown below.
    Figure 00050001
    wherein, R1 is benzoyl, 2-or 4-nitrophenylcarbonyl, 2- or 4-bromophenyl carbonyl, 2- or 4-chlorophenylcarbonyl, or 1- or 2-naphthylcarbonyl.
  • The compounds of the present invention can be illustrated as (S)-β-hydroxy-γ-butyrolactone (Ia), (R)-β-hydroxy-γ-butyrolactone (Ib), (S)-β-acetoxy-γ-butyrolactone (Ic), (R)-β-acetoxy-γ-butyrolactone (Id), (S)-β-benzyloxy-γ-butyrolactone, (R)-β-benzyloxy-γ-butyrolactone, (S)-β-benzoyloxy-γ-butyrolactone (Ie), (R)-β-benzoyloxy-γ-butyrolactone (If), (S)-β-[2-nitro(or 4-nitro)phenyl]carbonyloxy-γ-butyrolactone, (R)-β-[2-nitro(or 4-nitro) phenyl]carbonyloxy-γ-butyrolactone, (S)-β-[2-chloro-(or 4-chloro)phenyl]carbonyloxy-γ-butyrolactone, (R)-β- [2-chloro-(or 4-chloro)phenyl]carbonyloxy-γ-butyrolactone, (S)-β-[2-bromo-( or 4-bromo) phenyl]carbonyloxy-γ-butyrolactone, (R)-β-[2-bromo-( or 4-bromo)phenyl]carbonyloxy-γ-butyrolactone, (S)-β-[1-naphthyl-(or 2-naphthyl)]-γ-butyrolactone, (R)-β-[1-naphthyl (or 2-naphthyl)]carbonyloxy -γ-butyrolactone, or racemic mixtures thereof.
  • Among the above compounds, compounds (Ia), (Ib), (Ic) and (Id) are known compounds and compounds (Ie) and (If) etc., are novel compounds.
    Figure 00060001
    Figure 00060002
  • The above mentioned β-substituted-γ-butyrolactones are the important intermediates for the production of many pharmaceuticals, agrochemicals, flavors and fragrances.
  • Novel compounds of (Ie), (If) and derivatives thereof including (S)-[2-nitro(or 4-nitro)phenyl]carbonyloxy-γ-butyrolactone, (R)-[2-nitro(or 4-nitro)phenyl]carbonyloxy-γ-butyrolactone, (S)-β-[2-chloro-( or 4-chloro) phenyl]carbonyloxy-γ-butyrolactone, (R)-β-[2-chloro-(or 4-chloro)phenyl]carbonyloxy-γ-butyrolactone, (S)-β-[2-bromo-( or 4-bromo)phenyl]carbonyloxy-γ-butyrolactone, (R)-β-[2-bromo-(or 4-bromo)phenyl]carbonyloxy-γ-butyrolactone, (S)-β-[1-naphthyl-(or 2-naphthyl)]carbonyloxy-γ-butyrolactone, (R)-β-[1-naphthyl (or 2-naphthyl)]carbonyloxy-γ-butyrolactone, or racemic mixtures thereof newly prepared by the present invention have very good physical and chemical properties other than the known compounds (Ia), (Ib), (Ic) and (Id). Therefore, the novel compounds of the present invention can be used as important intermediates for the production of many pharmaceuticals, agrochemicals, flavors and fragrances.
  • Example 1 Preparation of (S)-β-Acetoxysuccinic Anhydride 2.
  • Acetyl chloride (8.8 g, 111.9 mmole) was added to ℓ-malic acid (5g-37.3 mmole) with stirring under nitrogen atmosphere and refluxed at 55-60°C., 3 hrs. When the evolution of hydrogen chloride gas stopped, the reaction mixture was cooled to room temperature, treated with THF (10ml) and then stirred for 10 min. The solvent and excess acetyl chloride were removed under a rotary evaporator. Diethyl ether (20ml) was added to the reaction mixture and stirred to obtain a white solid, 5.5g (92.2% yield); m.p. 56-57°C IR(KBr): 1871 and 1792 cm-1 (C=0, anhydride) and 1746 cm-1 (C=0, acetoxy group).
  • Example 2 Preparation of (S)-β-Benzoyloxysuccinic-Anhydride 3.
  • Benzoyl chloride (15.7 g, 111.9 mmole) was added to 1-malic (5.0g, 37.3 mmole) in 10 ml anhydrous THF with stirring at room temperature and heated to 80-85°C, for 3 hours. When the evolution of hydrogen chloride gas stopped, THF was distilled off under a rotary evaporator and diethyl ether (20ml) was added and stirred. A white solid was filtered, washed with 5ml of diethyl ether and dried to obtain 6.5 g (79.1% yield); m.p. 159-160°C.
  • IR (KBr) 1862 and 1789 cm-1 (C=0, anhydride) and 1708 cm-1(C=0, benzoyl).
  • Example 3 Preparation of (S)-β-Acetoxy-γ-Butyrolactone Ic.
  • To Zn(BH4)2 (1.44g,15.8mmole) in 24ml THF, (S)-β-Acetoxy-γ-succinic-anhydride 2 (5.0g, 31.6mmol) in 20ml THF was added below 5°C over 1 hour and stirred at room temperature for 3 hours. The reaction mixture was cooled again below 5°C, treated with 5ml of 6N HCI and stirred for half an hour. THF was removed under a rotary evaporator and oily water layer was extracted twice with 50ml of ethyl acetate. The combined ethyl acetate was dried over sodium sulfate, filtered and evaporated to yield 4.8g (85%) of yellow oil.
  • IR (KBr): 1738 (C=0, acetoxy) and 1784 cm-1 (C=0, lactone).
  • Example 4 Preparation of (S)-β-Benzoyloxy-γ-Butyrolactone Ie
  • To Zn(BH4)2 (0.62g,6.8mmole) in 10ml THF, (S)-β-benzoyloxy-γ-succinic-anhydride (3.0g, 13.6mmol) dissolved in 20ml THF was added slowly below 5°C over one hour and stirred at room temperature for 3 hours. The reaction mixture was cooled again below 5°C, treated with 5ml of 6N HCI solution and stirred for half an hour. 20ml of THF was removed under a rotary evaporator and kept at 5°C over night in a refrigerator.
  • 0.2g of white solid was obtained which was unknown impurity. The filtrate was concentrated to obtain 2.8g of white solid. The solid was dissolved in 100ml methylene chloride and extracted with 20ml of 1N HCl solution three times. The evaporation of methylene chloride yielded a white solid, 2.6g (88.0% yield); m.p. 73-74°C.
  • IR (KBr): 1716 (C=0, benzoyloxy) and 1770 cm-1 (C=0, lactone).
  • Example 5 Preparation of (R )-β-Benzoyloxy-γ-Butyrolactone If
  • By using (R)-β-benzoyloxy-γ-succinic anhydride instead of (S)-β-benzoyloxy-γ-succinic anhydride of Example 4, the titled compound was obtained.
  • Other compounds can be prepared by analogy method of example 3 or 4 by using proper starting materials.
  • It is intended that the foregoing description would be only illustrated for the present invention and that the present invention would be limited only by the hereinafter-appended.

Claims (7)

  1. A process for the preparation of butyrolactone or racemic mixture thereof of the formula (I) characterized in that the butyrolactone is a (S)- or (R)-β-substituted-λ-butyrolactone of the formula (I), obtainable by converting β-substituted-γ-succinic anhydrides of the formula (2) in the presence of zinc borohydride in a compatible solvent selected from tetrahydrofuran, methylene chloride, dichloromethane and ethyl acetate,
    Figure 00090001
    wherein R1 is hydrogen, acetyl, benzyl, benzoyl, 2-or 4-nitrophenylcarbonyl, 2- or 4-bromophenyl carbonyl, 2-or 4-chlorophenylcarbonyl, or 1- or 2-naphtylcarbonyl.
  2. A butyrolactone or racemic mixture thereof characterized in that the butyrolactone is a (S)- or (R)-β-substituted-λ-butyrolactone of the formulas (I-1) or (I-2),
    Figure 00090002
    wherein, R1 is benzoyl, 2-or 4-nitrophenylcarbonyl, 2- or 4-bromophenyl carbonyl, 2- or 4-chlorophenylcarbonyl, or 1- or 2-naphthylcarbonyl.
  3. The butyrolactone according to claim 2 characterized in that the butyrolactone is a (S)- or (R)-β-substituted-λ-butyrolactone selected from (S)-β-benzoyloxy-γ-butyrolactone (Ie), (R)-β-benzoyloxy-γ-butyrolactone (If), (S)-β-[2-nitro(or 4-nitro)phenyl]carbonyloxy-γ-butyrolactone, (R)-β-[2-nitro(or 4-nitro)phenyl]carbonyloxy-γ-butyrolactone, (S)-β[2-chloro-( or 4-chloro)phenyl]carbonyloxy-γ-butyrolactone, (R)-β-[2-chloro-( or 4-chloro)phenyl]carbonyloxy-γ-butyrolactone, (S)-β-[2-bromo-( or 4-bromo)phenyl]carbonyloxy-γ-butyrolactone, (R)-β-[2-bromo-(or 4-bromo)phenyl]-γ-butyrolactone, (S)-β-[1-naphthyl-(or 2-naphthyl)]-γ-butyrolactone, (R)-β-[1-naphthyl (or 2-naphthyl)]-γ-butyrolactone.
  4. A butyrolactone according to claim 2 characterized in that the butyrolactone is a (S)-β-benzoyloxy-γ-butyrolactone (Ie).
  5. A butyrolactone according to claim 2 characterized in that the butyrolactone is a (R)-β-benzoyloxy-γ-butyrolactone (If).
  6. A butyrolactone according to claim 2 characterized in that the butyrolactone is a (S)-β-benzoyloxycarbonyl-γ-butyrolactone.
  7. A butyrolactone according to claim 2 characterized in that the butyrolactone is a (R)-β-benzoyloxycarbonyl-γ-butyrolactone.
EP20020020643 2002-09-13 2002-09-13 Beta-substituted-gamma-butyrolactones and a process for preparation thereof Withdrawn EP1398312A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP20020020643 EP1398312A1 (en) 2002-09-13 2002-09-13 Beta-substituted-gamma-butyrolactones and a process for preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP20020020643 EP1398312A1 (en) 2002-09-13 2002-09-13 Beta-substituted-gamma-butyrolactones and a process for preparation thereof

Publications (1)

Publication Number Publication Date
EP1398312A1 true EP1398312A1 (en) 2004-03-17

Family

ID=31725428

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20020020643 Withdrawn EP1398312A1 (en) 2002-09-13 2002-09-13 Beta-substituted-gamma-butyrolactones and a process for preparation thereof

Country Status (1)

Country Link
EP (1) EP1398312A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112939901A (en) * 2021-02-09 2021-06-11 中国科学院福建物质结构研究所 Preparation method of alpha-hydroxy-gamma-butyrolactone

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5808107A (en) * 1997-10-31 1998-09-15 Board Of Trustees Operating Michigan State University Process for the preparation of hydroxy substituted gamma butyrolactones

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5808107A (en) * 1997-10-31 1998-09-15 Board Of Trustees Operating Michigan State University Process for the preparation of hydroxy substituted gamma butyrolactones

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
C. SOUCY ET AL.: "On the regioselectivity of metal hydride reductions of 3-substituted phthalic anhydrides", J. ORG. CHEM., vol. 52, no. 1, 9 January 1987 (1987-01-09), pages 129 - 134, XP002218905 *
D. H. R. BARTON ET AL.: "Studies related to the synthesis of maytansinoids", TETRAHEDRON LETT., vol. 23, no. 6, 1982, XP001117963 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112939901A (en) * 2021-02-09 2021-06-11 中国科学院福建物质结构研究所 Preparation method of alpha-hydroxy-gamma-butyrolactone
CN112939901B (en) * 2021-02-09 2023-05-09 中国科学院福建物质结构研究所 Preparation method of alpha-hydroxy-gamma-butyrolactone

Similar Documents

Publication Publication Date Title
HUT68255A (en) Process for the preparation of beta-phenylisoserine derivatives and use thereof
WO2008015977A1 (en) PROCESS FOR PRODUCTION OF (±)-3a,6,6,9a– TETRAMETHYLDECAHYDRONAPHTHO[2,1-b]FURAN-2(1H)-ONE
EP1008590B1 (en) Process for preparing optically active oxazolidinone derivatives
HU204247B (en) Process for optical resolving raceme compositions of alpha-naphtyl-propionic acid derivatives
JP7436689B2 (en) Method for producing γ-aminobutyric acid and its analogs
EP1398312A1 (en) Beta-substituted-gamma-butyrolactones and a process for preparation thereof
US5498799A (en) Process for producing optically active 2-norbornanone
JP2018135293A (en) Method for producing amide compound
JP2617960B2 (en) Stereoisomerization method for producing optically active carboxylic acids
KR100614546B1 (en) Tetrahydrofuran cyclic compounds having high stereoselectivity, and Process for preparing them
HU214086B (en) Process for producing 3-isoxazolecarboxylic acid and intermediates thereof
JPH09143173A (en) Optically active 5,5-diphenyl-2-oxazolidinone derivative
JP2004161614A (en) beta-SUBSTITUTED-gamma-BUTYROLACTONES AND METHOD FOR PRODUCING THE SAME
JP6979193B2 (en) Method for synthesizing α, β-unsaturated-γ-lactone derivative
KR100763770B1 (en) Process for preparing chiral intermediates useful in synthesis of atorvastatin
JP4428086B2 (en) Method for producing 1-acetoxy-3- (3,4-methylenedioxyphenyl) propene derivative
JP4661272B2 (en) Process for producing chiral 4-methyl-4-[(arylcarbooxy) ethyl] -oxetan-2-one and chiral mevalonolactone
JP4330783B2 (en) Method for producing formylcyclopropanecarboxylic acid ester
JP2006298872A (en) Manufacturing method of 1-fluoro-1-phenylthioethene
KR20020073751A (en) Beta-substituted-gamma-butyrolactones and preparation process thereof
JP3740783B2 (en) Process for producing 4- (2-alkenyl) -2,5-oxazolidinediones
KR100225534B1 (en) Stereospecific process for preparing (2r,3s)-beta--phenylisoserine
JP2000063321A (en) Production of long-chain beta-hydroxycarboxylic acid of high optical purity
JPH07291957A (en) Method and intermediate for producing 5-oxaspiro(2.4)hetan-6-one
KR100461561B1 (en) (S) -3-carboxy-4-bromobutyric acid production method

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020913

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

17Q First examination report despatched

Effective date: 20040920

AKX Designation fees paid

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

AXX Extension fees paid

Extension state: SI

Payment date: 20020913

Extension state: RO

Payment date: 20020913

Extension state: MK

Payment date: 20020913

Extension state: LV

Payment date: 20020913

Extension state: LT

Payment date: 20020913

Extension state: AL

Payment date: 20020913

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050201